India · Delayed Price · Currency is INR Hamps Bio Statistics
Total Valuation
Hamps Bio has a market cap or net worth of INR 161.26 million. The enterprise value is 188.18 million.
| Market Cap | 161.26M |
| Enterprise Value | 188.18M |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hamps Bio has 8.71 million shares outstanding. The number of shares has increased by 272.03% in one year.
| Current Share Class | 8.71M |
| Shares Outstanding | 8.71M |
| Shares Change (YoY) | +272.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 75.85% |
| Owned by Institutions (%) | n/a |
| Float | 2.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.26 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -115.52 |
| EV / Sales | 2.64 |
| EV / EBITDA | 45.55 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.44.
| Current Ratio | 2.65 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 9.04 |
| Debt / FCF | n/a |
| Interest Coverage | -0.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.19% |
| Return on Capital Employed (ROCE) | -0.57% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 949,360 |
| Profits Per Employee | -21,720 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Hamps Bio has paid 116,000 in taxes.
| Income Tax | 116,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -45.56% |
| 50-Day Moving Average | 22.21 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.70 |
| Average Volume (20 Days) | 9,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hamps Bio had revenue of INR 71.20 million and -1.63 million in losses. Loss per share was -0.14.
| Revenue | 71.20M |
| Gross Profit | 45.72M |
| Operating Income | -632,000 |
| Pretax Income | -1.51M |
| Net Income | -1.63M |
| EBITDA | 4.13M |
| EBIT | -632,000 |
| Loss Per Share | -0.14 |
Balance Sheet
The company has 10.44 million in cash and 37.36 million in debt, with a net cash position of -26.93 million or -3.09 per share.
| Cash & Cash Equivalents | 10.44M |
| Total Debt | 37.36M |
| Net Cash | -26.93M |
| Net Cash Per Share | -3.09 |
| Equity (Book Value) | 85.07M |
| Book Value Per Share | 9.57 |
| Working Capital | 35.01M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 64.22%, with operating and profit margins of -0.89% and -2.29%.
| Gross Margin | 64.22% |
| Operating Margin | -0.89% |
| Pretax Margin | -2.12% |
| Profit Margin | -2.29% |
| EBITDA Margin | 5.80% |
| EBIT Margin | -0.89% |
| FCF Margin | n/a |
Dividends & Yields
Hamps Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -272.03% |
| Shareholder Yield | -272.03% |
| Earnings Yield | -1.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 8, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Sep 8, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |